MedPath

Clinical Trial Analysisfor "Anaplastic Astrocytoma"

Study Phases Distribution

Distribution of trials by study phase

58.6%25.3%6.5%5.9%3.2%186Total
Phase 1: 109
Phase 2: 47
Phase 3: 12
Not Applicable: 11
Early Phase 1: 6
Phase 4: 1

Recruitment Status Distribution

Distribution of trials by recruitment status

Total: 202

Top Countries Distribution

Countries with most clinical trials

Top Companies Distribution

Companies with most clinical trials

CompanyCount
National Cancer Institute (NCI)44
Pediatric Brain Tumor Consortium8
City of Hope Medical Center7
Northwell Health7
INSYS Therapeutics Inc5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
Tocagen Inc.4
University of Alabama at Birmingham4
M.D. Anderson Cancer Center3
Mayo Clinic3

Top Conditions Distribution

Most studied medical conditions

ConditionCount
Anaplastic Astrocytoma122
Glioblastoma66
Glioblastoma Multiforme56
Anaplastic Oligodendroglioma46
Adult Anaplastic Astrocytoma35
Adult Giant Cell Glioblastoma34
Adult Anaplastic Oligodendroglioma33
Adult Gliosarcoma33
Gliosarcoma31
Adult Glioblastoma30

Top Interventions Distribution

Most common intervention types

InterventionCount
laboratory biomarker analysis37
pharmacological study28
Temozolomide26
Therapeutic Conventional Surgery16
Radiation Therapy14
Bevacizumab13
Quality-of-Life Assessment5
positron emission tomography5
Intensity-Modulated Radiation Therapy4
Lomustine4